Extended-spectrum β-lactamases in Pseudomonas aeruginosa

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 2, 1998, Pages 128-131

  Nordmann, Patrice ^a,b,c   Guibert, Michèle ^b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; BETA LACTAMASE;

EDITORIAL; PSEUDOMONAS AERUGINOSA;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CEFTAZIDIME; CEPHALOSPORINASE; CEPHALOSPORINS; ENZYME INHIBITORS; PSEUDOMONAS AERUGINOSA;

EID: 0031851624     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (34)

1. Normark, S. (1995). β-Lactamase induction in Gram-negative bacteria is intimately linked to peptidoglycan recycling. Microbial Drug Resistance 1, 111-4.
2. Bush, K., Jacoby, G. A. & Medeiros, A. A. (1995). A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrobial Agents and Chemotherapy 39, 1211-33.
3. Chen, H. Y., Yuan, M. & Livermore, D. M. (1995). Mechanisms of resistance to β-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993. Journal of Medical Microbiology 43, 300-9.
4. Chen, H. Y., Yuan, M., Ibrahim-Elmagboul, I. B. & Livermore, D. M. (1995). National survey of susceptibility to antimicrobials amongst clinical isolates of Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 35, 521-34.
5. Lodge, J. M., Minchin, S. D., Piddock, J. V. & Busby, J. W. (1990). Cloning, sequencing and analysis of the structural gene and regulatory region of the Pseudomonas aeruginosa chromosomal AmpC β-lactamase. Biochemical Journal 272, 627-31.
6. Sanders, C. C., Gates, M. L. & Sanders, W. E. (1988). Heterogeneity of class I β-lactamase expression in clinical isolates of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 32, 1893-5.
7. Campbell, J. I., Ciofu, O. & Hoiby, N. (1997). Pseudomonas aeruginosa isolates from patients with cystic fibrosis have different β-lactamase expression phenotypes but are homogeneous in the ampC-ampR genetic region. Antimicrobial Agents and Chemotherapy 41, 1380-4.
8. Itokazu, G. S., Quinn, J. P., Bell-Dixon, C., Kahan, F. M. & Weinstein, R. A. (1996). Antimicrobial resistance rates among aerobic Gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clinical Infectious Diseases 23, 779-84.
9. Spencer, R. C. (1996). An 8 year Microbe Base survey of the epidemiology, frequency and antibiotic susceptibility of Pseudomonas aeruginosa hospital isolates in the United Kingdom. Journal of Antimicrobial Chemotherapy 37, 295-301.
10. Bauernfeind, A., Wagner, S., Jungwirth, R., Schneider, I. & Meyer, D. (1997). A novel class C β-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins. Antimicrobial Agents and Chemotherapy 41, 2041-6.
11. Nordmann, P., Ronco, E., Naas, T., Duport, C., Michel-Briand, Y. & Labia, R. (1993). Characterization of a novel extended-spectrum β-lactamase from Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 37, 962-9.
12. Nordmann, P. & Naas, T. (1994). Sequence analysis of PER-1 extended-spectrum β-lactamase from Pseudomonas aeruginosa and comparison with class A β-lactamases. Antimicrobial Agents and Chemotherapy 38, 104-14.
13. Mugnier, P., Dubrous, S., Casin, I., Arlet, G. & Collatz, E. (1996). A TEM-derived extended spectrum β-lactamase in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 40, 2488-93.
14. Nordmann, P., Philippon, L. N., Ronco, E. & Naas, T. (1997). SHV extended-spectrum β-lactamase from Pseudomonas aeruginosa. In Program and Abstracts of the Thirty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 1997. Abstract C24. American Society for Microbiology, Washington, DC.
15. Danel, F., Hall, L. M., Gür, D., Akalin, H. E. & Livermore, D. M. (1995). Transferable production of PER-1 β-lactamase in Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 35, 281-94.
16. Vahaboglu, H., Ozturk, R., Aygun, G., Coskunkan, F., Yaman, A., Kaygusuz, A. et al. (1997). Widespread detection of PER-1 type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrobial Agents and Chemotherapy 41, 2265-9.
17. Vahaboglu, H., Hall, L. M., Mulazimoglu, L., Dodanli, S., Yildirim, I. & Livermore, D. M. (1995). Resistance to extended-spectrum cephalosporins, caused by PER-1 β-lactamase, in Salmonella typhimurium from Istanbul, Turkey. Journal of Medical Microbiology 43, 294-9.
18. Casin, I., Hanau, B., Mugnier, P., Vahaboglu, H. & Collatz, E. (1997). Amikacin-resistance determinant of plasmid pSTI1 from Salmonella typhimurium is associated with a Tn-21-like transposon encoding the extended-spectrum β-lactamase PER-1. In Program and Abstracts of the Thirty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 1997. Abstract C122. American Society for Microbiology, Washington, DC.
19. PER-2, which encodes an extended-spectrum class A β-lactamase. Antimicrobial Agents and Chemotherapy 40, 616-20.
20. Minami, S., Akama, M., Araki, H., Watanabe, Y., Narita, H., Iyobe, S. et al. (1996). Imipenem and cephem resistant Pseudomonas aeruginosa carrying plasmids coding for class B β-lactamase. Journal of Antimicrobial Chemotherapy 37, 433-44.
21. IMP. Antimicrobial Agents and Chemotherapy 39, 1612-5.
22. IMP among clinically isolated strains of Serratia marcescens. Antimicrobial Agents and Chemotherapy 39, 824-9.
23. Osano, E., Arakawa, Y., Wacharotayankun, R., Ohta, M., Horii T., Ito, H. et al. (1994). Molecular characterization of an enterobacterial metallo β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrobial Agents and Chemotherapy 38, 71-8.
24. IMP) in Gram-negative rods resistant to broad-spectrum β-lactams. Journal of Clinical Microbiology 34, 2909-13.
25. Senda, K., Arakawa, Y., Nakashima, K., Ito, H., Ichiyama, S., Shimokata, K. et al. (1996). Multifocal outbreaks of metallo-β-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems. Antimicrobial Agents and Chemotherapy 40, 349-53.
26. Dib, C., Trias, J. & Jarlier, V. (1995). Lack of additive effect between mechanisms of resistance to carbapenems and other β-lactam agents in Pseudomonas aeruginosa. European Journal of Clinical Microbiology and Infectious Diseases 14, 979-86.
27. Hall, L. M., Livermore, D. M., Gür, D., Akova, M. & Akalin, H. E. (1993). OXA-11, an extended-spectrum variant of OXA-10 (PSE-2). β-lactamase from Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 37, 1637-44.
28. Danel, F., Hall, L. M., Gür, D. & Livermore, D. M. (1995). OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) β-lactamase from Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 39, 1881-4.
29. Danel, F., Hall, L. M., Gür, D. & Livermore, D. M. (1996). OXA-16, a new OXA-10-related β-lactamase giving ceftazidime resistance in Pseudomonas aeruginosa in Turkey. In Program and Abstract of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996. Abstract C27. American Society for Microbiology, Washington, DC.
30. Danel, F., Hall, L. M., Gür, D. & Livermore, D. M. (1997). OXA-15, an extended-spectrum variant of OXA-2 β-lactamase, isolated from Pseudomonas aeruginosa strain. Antimicrobial Agents and Chemotherapy 41, 785-90.
31. Dale, J. W., Godwin, D., Mossakowska, D., Stephenson, P. & Wall, S. (1985). Sequence of the OXA-2 β-lactamase: comparison with other penicillin-reactive enzymes. FEBS Letters 191, 39-44.
32. Philippon, L. N., Naas, T., Bouthors, A. T., Barakett, V. & Nordmann, P. (1997). OXA-18, a class D clavulanic-acid inhibited extended-spectrum β-lactamase from Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 41, 2188-95.
33. Naas, T., Sougakoff, W., Casetta, A. & Nordmann, P. (1997). Molecular characterization of OXA-20, a peculiar class D β-lactamase from Pseudomonas aeruginosa. In Program and Abstracts of the Thirty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 1997. Abstract C193. American Society for Microbiology, Washington, DC.
34. Philippon, A. (1998). Pseudomonas aeruginosa: phénotypes de résistance aux antibiotiques. Médecine et Maladies Infectieuses 28, 134-49.